fda remove semaglutide from shortage list status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy drug GLP-1 No Longer on FDA's – US FDA proposes curbs on

Our dedicated providers take the time to get to know each patient and build long-term relationships around achieving and maintaining transformational results

Is naltrexone/bupropion a GLP-1 active ingredient

One fact untangles most of the confusion in any list of GLP-1 medications: the same molecule is often sold under two different brand names, one approved for type 2 diabetes and one for weight management

We covered the regulatory landscape in the post on the FDA peptide crackdown

The website is packed with bold claims: Endorsed by Stanford professors Used by over 2.25 million people Clinically proven and certified by national authorities Backed by endocrinology experts like Dr